Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Robbert J.C. Slebos(University of Iowa), Christine H. Chung(Moffitt Cancer Center), Brian B. Burkey(University of Colorado Cancer Center), James L. Netterville(Breast Cancer Research Foundation), Shawn Levy(HudsonAlpha Institute for Biotechnology), Amy Evjen(Vanderbilt University), Anthony J. Cmelak(Breast Cancer Research Foundation), Yajun Yi(Vanderbilt University), Yu Shyr(Vanderbilt University), Jesse Carter(University of Colorado Cancer Center), Xueqiong Zhang(Peking University), Wendell G. Yarbrough(University of North Carolina at Chapel Hill), Kim Ely(Bipar), Barbara Murphy(The University of Melbourne)
Cited by 316
Related Papers
Next-generation genotype imputation service and methods
|Nature Genetics|2016|4.5k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k